Homology Medicines Future Growth
How is Homology Medicines forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FIXX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FIXX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FIXX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: FIXX's revenue (64.8% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: FIXX's revenue (64.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FIXX is forecast to be unprofitable in 3 years.